Tuesday, April 14, 2009

Vectical Offers New Treatment Option for Psoriasis
Vectical (calcitriol) Ointment from Galderma Laboratories, available in Europe for many years, is now approved for use in the U.S. by the FDA for the treatment of psoriasis.
Vectical is a naturally occurring, active form of vitamin D3. It is similar to an established treatment, calcipotriol/calcipotriene, but appears to be better tolerated with less redness (erythema) and stinging/burning, especially when applied to sensitive areas, such as the face, hairline, inner elbow, and groin.

Calcitriol ointment is ideally suited for application to localized psoriasis plaques.

Like calcipotriol, Vectical ointment will likely be used in combination with topical corticosteroids, or as maintenance therapy. Vectical may also play a role as a long-term and safe medication for long-term control.

Learn more about a resurgence in the use of topical therapies for the treatment of psoriasis.

No comments:

Post a Comment

Thank you for commenting on the FromYourDoctor blog.